Specialized CRO AVIVA operates as a contract research organization focusing on safety screening with emphasis on ion channels and cardiovascular mechanics, presenting a clear ready-made CRO pathway for pharma and biotech partners seeking electrophysiology expertise.

Custom Assays All assays are customizable across formats such as Langendorff, Purkinje, and human tissue, enabling tailored safety and efficacy studies for clients with specific ion channel or cardiac physiology needs.

Proprietary Tech The RedSift Filter System and Sealchip16 voltage clamp platform represent unique capabilities for cell isolation and automated electrophysiology, which can differentiate AVIVA in competitive bids for high-throughput or specialized assays.

Rare Cell Focus Capabilities to isolate and analyze rare cells, circulating tumor cells, and small-volume samples open opportunities with oncology-linked safety evaluations, translational research, and pediatric or scarce-sample studies.

Growth Opportunitie With modest headcount and multiple funding rounds, AVIVA could expand collaborations with larger CROs or pharma companies seeking niche electrophysiology and cardiotoxicity testing, particularly for hERG and ion channel profiling.